Grant: Project Grant - Priority Announcement: Patient-Oriented Research
McMaster University
$100,000.00
A Clinical Prediction Model for the Diagnosis of Immune Thrombocytopenia
FY 2021-22
Summary
Immune thrombocytopenia (ITP) is a common blood disorder caused by low blood platelets and a high risk for bleeding. Doctors often get the diagnosis wrong because other conditions can mimic ITP. This can be dangerous for patients because it results in long delays in getting the appropriate care, and patients are exposed to unnecessary treatments that can be harmful and costly. Mistakes in making the diagnosis of ITP is a top concern for patients.
Our group developed the Predict-ITP Tool for doctors to use when faced a patient with low blood platelets. We determined specific patient-related features that were associated with the reference standard for ITP, which we defined as a platelet count rise after ITP-specific treatments. Using statistical models based on a group of 629 patients who had been referred to a hematologist with suspected ITP, we identified the following variables for the Predict-ITP Tool: 1) extent of platelet count fluctuations over time; 2) lowest platelet count value; 3) highest mean platelet volume; and 4) history of a major bleed. We completed the internal validation of the Predict-ITP Tool, which showed very promising results.
The objective of this study is to conduct an external validation of the Predict-ITP Tool across a broad range of patients from academic and community hematology clinics. We require 765 patients to complete this external validation study and so we are collaborating with hematologists from 10 clinics across Canada. We will design a web-based application so that the tool is readily available to help doctors make an accurate diagnosis.
Our team includes ITP researchers, hematologists, biostatisticians, methodologists and a patient representative. Our research will improve patient care, avoid unnecessary treatments, and save on healthcare costs.
Department
Program
Project Grant - Priority Announcement: Patient-Oriented Research
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
456786
Name
Arnold Donald M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Projecttitle
A Clinical Prediction Model for the Diagnosis of Immune Thrombocytopenia
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Patient-Oriented Research
Keyworddelim
Autoimmune Disease; Clinical Prediction Model; Diagnosis; Immune Thrombocytopenia (Itp); Platelets
Abstract
Immune thrombocytopenia (ITP) is a common blood disorder caused by low blood platelets and a high risk for bleeding. Doctors often get the diagnosis wrong because other conditions can mimic ITP. This can be dangerous for patients because it results in long delays in getting the appropriate care, and patients are exposed to unnecessary treatments that can be harmful and costly. Mistakes in making the diagnosis of ITP is a top concern for patients.
Our group developed the Predict-ITP Tool for doctors to use when faced a patient with low blood platelets. We determined specific patient-related features that were associated with the reference standard for ITP, which we defined as a platelet count rise after ITP-specific treatments. Using statistical models based on a group of 629 patients who had been referred to a hematologist with suspected ITP, we identified the following variables for the Predict-ITP Tool: 1) extent of platelet count fluctuations over time; 2) lowest platelet count value; 3) highest mean platelet volume; and 4) history of a major bleed. We completed the internal validation of the Predict-ITP Tool, which showed very promising results.
The objective of this study is to conduct an external validation of the Predict-ITP Tool across a broad range of patients from academic and community hematology clinics. We require 765 patients to complete this external validation study and so we are collaborating with hematologists from 10 clinics across Canada. We will design a web-based application so that the tool is readily available to help doctors make an accurate diagnosis.
Our team includes ITP researchers, hematologists, biostatisticians, methodologists and a patient representative. Our research will improve patient care, avoid unnecessary treatments, and save on healthcare costs.
Competitiondate
202109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arnold, Donald M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~